UnitedHealth Group (NYSE:UNH) Price Target Lowered to $510.00 at Robert W. Baird

UnitedHealth Group (NYSE:UNH) had its price target cut by Robert W. Baird from $640.00 to $510.00 in a research note issued to investors on Tuesday morning,Benzinga reports. They currently have an outperform rating on the healthcare conglomerate’s stock.

Other analysts have also issued reports about the stock. Raymond James reiterated a “strong-buy” rating and issued a $540.00 price target (down from $635.00) on shares of UnitedHealth Group in a research report on Monday, April 21st. KeyCorp cut their price target on UnitedHealth Group from $650.00 to $575.00 and set an “overweight” rating for the company in a report on Monday, April 21st. Piper Sandler dropped their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Three research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and three have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Buy” and an average target price of $596.86.

UnitedHealth Group Trading Down 2.6 %

Shares of UNH opened at $409.23 on Tuesday. The firm’s 50-day moving average is $499.59 and its two-hundred day moving average is $532.08. The firm has a market capitalization of $372.49 billion, a P/E ratio of 26.40, a PEG ratio of 1.37 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group has a twelve month low of $409.10 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter in the previous year, the firm posted $6.91 earnings per share. On average, research analysts predict that UnitedHealth Group will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 2.05%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.18%.

Institutional Investors Weigh In On UnitedHealth Group

Large investors have recently modified their holdings of the stock. U.S. Capital Wealth Advisors LLC lifted its position in shares of UnitedHealth Group by 63.5% during the first quarter. U.S. Capital Wealth Advisors LLC now owns 18,749 shares of the healthcare conglomerate’s stock worth $9,820,000 after purchasing an additional 7,279 shares in the last quarter. Pacific Point Advisors LLC increased its position in shares of UnitedHealth Group by 2.3% during the first quarter. Pacific Point Advisors LLC now owns 3,958 shares of the healthcare conglomerate’s stock worth $2,073,000 after acquiring an additional 89 shares during the last quarter. Brass Tax Wealth Management Inc. grew its stake in UnitedHealth Group by 5.6% during the 1st quarter. Brass Tax Wealth Management Inc. now owns 756 shares of the healthcare conglomerate’s stock valued at $396,000 after purchasing an additional 40 shares in the last quarter. Security National Bank of SO Dak raised its position in shares of UnitedHealth Group by 25.4% in the 1st quarter. Security National Bank of SO Dak now owns 1,343 shares of the healthcare conglomerate’s stock valued at $703,000 after purchasing an additional 272 shares in the last quarter. Finally, Capital Advisors Inc. OK grew its position in shares of UnitedHealth Group by 1.5% during the first quarter. Capital Advisors Inc. OK now owns 77,077 shares of the healthcare conglomerate’s stock worth $40,369,000 after buying an additional 1,103 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.